Empire Genomics (EG) is a molecular diagnostics and clinical services company that develops and offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients. The EG services are designed to specifically meet the needs of pathologists, oncologists and researchers. Our mission is to address the problem the medical community faces with the rapid pace of molecular technology innovations, and the need for the delivery of clinically relevant, cost effective patient decision support tools. Ultimately, through our continued growth customers will be able to realize: faster and more effective drug development, lower healthcare costs, and better clinical outcomes for patients. Empire is uniquely positioned to bring this innovative service to the medical community through its highly qualified team, state of the art facilities and key strategic partnerships with leaders in the global research community. We are a resource to make personalized medicine a reality for you.